Canine B Burgdorferi *2 Alu Kb
356 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
356
Total Reports
14
Deaths Reported
390.0%
Death Rate
Active Ingredients
Canine B Burgdorferi *2 Alu Kb
Administration Routes
SubcutaneousUnknownOral
Species Affected
Dog 356
Most Affected Breeds
Crossbred Canine/dog 80
Retriever - Labrador 51
Retriever - Golden 36
Shepherd Dog - German 13
Shepherd Dog - Australian 11
Beagle 9
Terrier (unspecified) 7
Shih Tzu 6
Siberian Husky 6
Boxer (German Boxer) 6
Most Reported Reactions
Lack of efficacy (bacteria) - Borrelia 159
Lack of efficacy (bacteria) - NOS 104
Lack of efficacy (tick) 101
Lack of efficacy (ectoparasite) - tick NOS 86
Lack of efficacy (bacteria) - Anaplasma 29
Vomiting 22
Lethargy (see also Central nervous system depression in 'Neurological') 12
Emesis (multiple) 12
Seizure NOS 10
Death by euthanasia 10
Drug dose administration interval too long 10
Injection site lump 9
Outcome Breakdown
Ongoing
241 (67.7%)
Recovered/Normal
78 (21.9%)
Outcome Unknown
22 (6.2%)
Euthanized
10 (2.8%)
Died
4 (1.1%)
Recovered with Sequela
1 (0.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.